Amgen halts pancreatic cancer drug trial
17:40 EDT 8 Aug 2012 | R&D Magazine
Biotech drugmaker Amgen Inc. said Wednesday that it is halting a study of an experimental drug for reoccurring pancreatic cancer due to disappointing results.The company said a board of medical experts recommended ending the trial because the drug,..
Original Article: Amgen halts pancreatic cancer drug trial
More From BioPortfolio on "Amgen halts pancreatic cancer drug trial"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
